# Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

> **NCT00661622** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 53 (actual)

## Conditions studied

- Uveal Melanoma
- Liver Metastases

## Interventions

- **DRUG:** GM-CSF
- **PROCEDURE:** Embolization

## Key facts

- **NCT ID:** NCT00661622
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661622, "Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00661622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*